Catalyst Wire Dossier Catalyst Wire Dossier

Lu AG09222

· H. Lundbeck A/S
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lu AG09222, covering 2024-02-08 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments [Phase 2]

See pricing